These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14695040)

  • 41. Effects of intensive interventions compared to standard care in people with type 2 diabetes and microalbuminuria on risk factors control and cardiovascular outcomes: A systematic review and meta-analysis of randomised controlled trials.
    Usman M; Gillies CL; Khunti K; Davies MJ
    Diabetes Res Clin Pract; 2018 Dec; 146():76-84. PubMed ID: 30312714
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microalbuminuria and subclinical cerebrovascular damage in essential hypertension.
    Ravera M; Ratto E; Vettoretti S; Viazzi F; Leoncini G; Parodi D; Tomolillo C; Del Sette M; Maviglio N; Deferrari G; Pontremoli R
    J Nephrol; 2002; 15(5):519-24. PubMed ID: 12455718
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cognitive impairment and risk of cardiovascular events and mortality.
    O'Donnell M; Teo K; Gao P; Anderson C; Sleight P; Dans A; Marzona I; Bosch J; Probstfield J; Yusuf S
    Eur Heart J; 2012 Jul; 33(14):1777-86. PubMed ID: 22551598
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microalbuminuria and cardiovascular risk.
    Lydakis C; Lip GY
    QJM; 1998 Jun; 91(6):381-91. PubMed ID: 9709456
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic significance of a reduced glomerular filtration rate and interaction with microalbuminuria in resistant hypertension: a cohort study.
    Salles GF; Cardoso CR; Pereira VS; Fiszman R; Muxfeldt ES
    J Hypertens; 2011 Oct; 29(10):2014-23. PubMed ID: 21873887
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High overall cardiovascular risk and mortality in patients with atrial fibrillation and diabetes: A nationwide report.
    Karayiannides S; Lundman P; Friberg L; Norhammar A
    Diab Vasc Dis Res; 2018 Jan; 15(1):31-38. PubMed ID: 29052435
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypertension and diabetes: a toxic combination.
    Bell DS
    Endocr Pract; 2008 Nov; 14(8):1031-9. PubMed ID: 19095606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The prevalence of hypertension and microalbuminuria in diabetes mellitus type 1 and type 2].
    Vasović O; Zamaklar M; Lalić K; Milosević D; Zikić L; Popović L
    Srp Arh Celok Lek; 2005; 133(5-6):229-32. PubMed ID: 16392277
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The prevalence of albuminuria among diabetic patients in a primary care setting in Singapore.
    Lee ES; Tang WE
    Singapore Med J; 2015 Dec; 56(12):681-6. PubMed ID: 26702164
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk factors that predict development of microalbuminuria in treated hypertensive men. The Risk Factor Intervention Study Group.
    Agewall S; Fagerberg B
    Angiology; 1996 Oct; 47(10):963-72. PubMed ID: 8873582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic implications of retinopathy and a high plasma von Willebrand factor concentration in type 2 diabetic subjects with microalbuminuria.
    Jager A; van Hinsbergh VW; Kostense PJ; Emeis JJ; Nijpels G; Dekker JM; Heine RJ; Bouter LM; Stehouwer CD
    Nephrol Dial Transplant; 2001 Mar; 16(3):529-36. PubMed ID: 11239027
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inclusion of albuminuria in hypertension and heart guidelines.
    Bakris G
    Kidney Int Suppl; 2004 Nov; (92):S124-5. PubMed ID: 15485406
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microalbuminuria is associated with unfavourable cardiac geometric adaptations in essential hypertensive subjects.
    Tsioufis C; Stefanadis C; Toutouza M; Kallikazaros I; Toutouzas K; Tousoulis D; Pitsavos C; Papademetriou V; Toutouzas P
    J Hum Hypertens; 2002 Apr; 16(4):249-54. PubMed ID: 11967718
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blood pressure targets for hypertension in people with diabetes mellitus.
    Arguedas JA; Leiva V; Wright JM
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD008277. PubMed ID: 24170669
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trials.
    Bilous R; Chaturvedi N; Sjølie AK; Fuller J; Klein R; Orchard T; Porta M; Parving HH
    Ann Intern Med; 2009 Jul; 151(1):11-20, W3-4. PubMed ID: 19451554
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Microalbuminuria in hypertension].
    Sakata S; Kimura G
    Nihon Rinsho; 2004 Jan; 62(1):97-102. PubMed ID: 14737841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Microalbuminuria--a valuable diagnostic parameter].
    Feldt-Rasmussen BF; Borch-Johnsen K; Deckert T; Jensen G; Jensen JS
    Ugeskr Laeger; 1993 Dec; 155(51):4149-54. PubMed ID: 8273236
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Low reporting of clinical characteristics of patients with diabetes mellitus included in the main clinical trials on hypertension].
    González-Clemente JM; Giménez-Palop O; Caixàs A; Barahona MJ; Subías D; Vilardell C; Giménez-Pérez G; Mauricio D
    Med Clin (Barc); 2005 Jul; 125(5):173-8. PubMed ID: 16153357
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urinary albumin excretion at follow-up predicts cardiovascular outcomes in subjects with resistant hypertension.
    Oliveras A; Armario P; Sierra C; Arroyo JA; Hernández-del-Rey R; Vazquez S; Larrousse M; Sans L; Roca-Cusachs A; de la Sierra A
    Am J Hypertens; 2013 Sep; 26(9):1148-54. PubMed ID: 23747954
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.